Metformin-related lactic acidosis: is it a myth or an underestimated reality?

References

• Guo PY, Storsley LJ, Finkle SN. Severe lactic acidosis treated with prolonged hemodialysis: Recovery after massive overdoses of metformin. Semin Dial. 2006;19:80–83.
   PubMed Web of Science ®Google Scholar
• Frid A, Sterner GN, Löndahl M, et al. Novel assay of metformin levels in patients with type 2 Diabetes and varying levels of renal function: Clinical recommendations. Diabetes Care. 2010;33:1291–1293.
   PubMed Web of Science ®Google Scholar
• Badawy A, Elnashar A. Treatment options for polycystic ovary syndrome. Int J Womens Health. 2011;3:25–35.
   PubMedGoogle Scholar
• Bellinghieri G, Bernardi A, Piva M, et al. Metabolic syndrome after kidney transplantation. J Ren Nutr. 2009;19:105–110.
   PubMed Web of Science ®Google Scholar
• Morales AI, Detaille D, Prieto M, et al. Metformin prevents experimental Gentamicin-Induced Nephropathy by a mitochondria-dependent pathway. Kidney Int. 2010;77:861–869.
   PubMed Web of Science ®Google Scholar
• Scheen AJ, Paquot N. Metformin revisited: A critical review of the benefit-risk balance in at-risk patients with type 2 diabetes. Diabetes Metab. 2013;39:179–190.
   PubMed Web of Science ®Google Scholar
• Lalau JD, Race JM. Lactic acidosis in metformin therapy: Searching for a link with metformin in reports of ‘metformin-associated lactic acidosis’. Diabetes Obes Metab. 2001;3:195–201.
   PubMed Web of Science ®Google Scholar
• Lalau JD. Lactic acidosis induced by metformin: Incidence, management and prevention. Drug Saf. 2010;33:727–740.
   PubMed Web of Science ®Google Scholar
• Scarpello JH, Howlett HC. Metformin therapy and clinical uses. Diab Vasc Dis Res. 2008;5:157–167.
   PubMed Web of Science ®Google Scholar
• Rocha A, Almeida M, Santos J, et al. Metformin in patients with chronic kidney disease: Strengths and weaknesses. J Nephrol. 2013;26:55–60.
   PubMed Web of Science ®Google Scholar
• Salpeter SR, Greyber E, Pasternak GA, et al. Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus. Cochrane Database Syst Rev. 2010;(4):CD002967.
   Google Scholar
• Vecchio S, Protti A. Metformin-induced lactic acidosis: No one left behind. Crit Care. 2011;15:107.
   PubMed Web of Science ®Google Scholar
• Klachko D, Whaley-Connell A. Use of metformin in patients with kidney and cardiovascular diseases. Cardiorenal Med. 2011;1:87–95.
   PubMed Web of Science ®Google Scholar
• Pilmore HL. Review: Metformin: Potential benefits and use in chronic kidney disease. Nephrology. 2010;15:412–418.
   PubMed Web of Science ®Google Scholar
• Nye HJ, Herrington WG. Metformin: The safest hypoglycaemic agent in chronic kidney disease? Nephron Clin Pract. 2011;118:380–383.
   PubMed Web of Science ®Google Scholar
• Holman RR, Paul SK, Bethel MA, Matthews DR, Neil HAW. 10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med. 2008;359:1577–1589.
   PubMed Web of Science ®Google Scholar
• Kooy A, Jager J, Lehert P, et al. Long term effects of metformin on metabolism and microvascular and macrovascular disease in patients with type 2 diabetes mellitus. Arch Intern Med. 2009;169:616–625.
   PubMed Web of Science ®Google Scholar
• Vecchio S, Giampreti A, Petrolini VM, et al. Metformin accumulation: Lactic acidosis and high plasmatic metformin levels in a retrospective case series of 66 patients on chronic therapy. Clin Toxicol (Phila). 2014;52:129–135.
   PubMed Web of Science ®Google Scholar
• Renda F, Mura P, Finco G, et al. Metformin-associated lactic acidosis requiring hospitalization. A national 10 year survey and a systematic literature review. Eur Rev Med Pharmacol Sci. 2013;17:45–49 [Database].
   PubMed Web of Science ®Google Scholar
• Spiller A, Quadrani DA. Toxic effects from metformin exposures. Ann Pharmacother. 2004;38:776–780.
   PubMed Web of Science ®Google Scholar
• Al-Abri SA, Hayashi S, Thoren KL, Olson KR. Metformin overdose-induced hypoglycemia in the absence of other antidiabetic drugs. Clin Toxicol (Phila). 2013;51:444–447.
   PubMed Web of Science ®Google Scholar
• Zhou G, Myers R, Li Y, et al. Role of AMP-activated protein kinase in mechanism of metformin action. J Clin Invest. 2001;108:1167–1174.
   PubMed Web of Science ®Google Scholar
• Protti A, Lecchi A, Fortunato F, et al. Metformin overdose causes platelet mitochondrial dysfunction in humans. Crit Care. 2012;16:R180.
   PubMed Web of Science ®Google Scholar
• Graham GG, Punt J, Arora M, et al. Clinical pharmacokinetics of metformin. Clin Pharmacokinet. 2011;50:81–98.
   PubMed Web of Science ®Google Scholar
• Lalau JD, Lacroix C. Measurement of metformin concentration in erythrocytes: Clinical implications. Diabetes Obes Metab. 2003;5:93–98.
   PubMed Web of Science ®Google Scholar
• Perrone J, Phillips C, Gaieski D. Occult metformin toxicity in three patients with profound lactic acidosis. J Emerg Med. 2011;40:271–275.
   PubMed Web of Science ®Google Scholar
• Pan LT, Maclaren G. Continuous venovenous haemodiafiltration for metformin-induced lactic acidosis. Anaesth Intensive Care. 2009;37:830–832.
   PubMed Web of Science ®Google Scholar
• Buemi M, Lacquaniti A, Bolignano D, et al. Dialysis and the elderly: An underestimated problem. Kidney Blood Press Res. 2008;31:330–336.
   PubMed Web of Science ®Google Scholar
• Sambol NC, Chiang J, O’Conner M, Liu CY, Lin ET, et al. Pharmacokinetics and pharmacodynamics of metformin in healthy subjects and patients with noninsulin-dependent diabetes mellitus. J Clin Pharmacol. 1996;36:1012–1021.
   PubMed Web of Science ®Google Scholar
• Gan SC, Barr J, Arieff AI, Pearl RG. Biguanide-associated lactic acidosis. Case report and review of the literature. Arch Intern Med. 1992;152:2333–2336.
   PubMed Web of Science ®Google Scholar
• Seidowsky A, Nseir S, Houdret N, et al. Metformin-associated lactic acidosis: A prognostic and therapeutic study. Crit Care Med. 2009;37:2191–2196.
   PubMed Web of Science ®Google Scholar
• Nguyen H. Metformin intoxication requiring dialysis. Hemodial Int. 2011;15:S68–S71.
   Web of Science ®Google Scholar
• Keller G, Cour M, Hernu R, et al. Management of metformin-associated lactic acidosis by continuous renal replacement therapy. PLoS One. 2011;6:e23200.
   PubMed Web of Science ®Google Scholar
• Lacquaniti A, Donato V, Pintaudi B, et al. “Normoalbuminuric” diabetic nephropathy: tubular damage and NGAL. Acta Diabetol. 2013;50:935–942.
   PubMed Web of Science ®Google Scholar
• Cryer DR, Nicholas SP, Henry DH, et al. Comparative outcomes study of metformin intervention versus conventional approach the COSMIC Approach Study. Diabetes Care. 2005;28:539–543.
   PubMed Web of Science ®Google Scholar